Moneycontrol PRO
HomeNewsBusinessPersonal FinanceConsidering cholesterol-reducing jabs? Inform your insurer so

Considering cholesterol-reducing jabs? Inform your insurer so

Insurers may selectively cover emerging cholesterol medication. But those who have taken the injection as part of a clinical trial need to inform the insurer as their risk assessment changes.

July 05, 2024 / 11:13 IST
About 15 percent of rural and 25-30 percent of urban population suffers from hypercholesterolemia – commonly referred to as high cholesterol, according to ICMR-INDIAB 2023 study.
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts